-
Signature
-
/s/ Karole Morgan-Prager, Attorney-in-Fact
-
Stock symbol
-
BL
-
Transactions as of
-
Sep 27, 2024
-
Transactions value $
-
-$220,272
-
Form type
-
4
-
Date filed
-
9/30/2024, 04:11 PM
Transactions Table
Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
transaction |
BL |
Common Stock |
Options Exercise |
$42.5K |
+3.03K |
+1.34% |
$14.00 |
230K |
Sep 27, 2024 |
Direct |
F1 |
transaction |
BL |
Common Stock |
Sale |
-$161K |
-3.03K |
-1.32% |
$53.00 |
227K |
Sep 27, 2024 |
Direct |
F1 |
transaction |
BL |
Common Stock |
Options Exercise |
$36.6K |
+2.62K |
+1.15% |
$14.00 |
229K |
Sep 27, 2024 |
Direct |
F1 |
transaction |
BL |
Common Stock |
Sale |
-$139K |
-2.62K |
-1.14% |
$53.00 |
227K |
Sep 27, 2024 |
Direct |
F1 |
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Underlying Class |
Amount |
Exercise Price |
Ownership |
Footnotes |
transaction |
BL |
Stock Option (Right to Buy) |
Options Exercise |
$0 |
-3.03K |
-7.11% |
$0.00 |
39.6K |
Sep 27, 2024 |
Common Stock |
3.03K |
$14.00 |
Direct |
F1, F2 |
transaction |
BL |
Stock Option (Right to Buy) |
Options Exercise |
$0 |
-2.62K |
-5.42% |
$0.00 |
45.7K |
Sep 27, 2024 |
Common Stock |
2.62K |
$14.00 |
Direct |
F1, F2 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
Explanation of Responses: